Bremelanotide is indicated for treatment of premenopausal women with acquired, generalized HSDD, which is marked by reduced sexual desire that causes distress or interpersonal difficulty. Acquired HSDD develops in a patient who previously had no problems with sexual desire; generalized HSDD occurs regardless of the type of situation, stimulation, or partner. In contrast, situational HSDD occurs due to problems with the relationship, a coexisting medical or psychiatric condition, or effects of a medication or drug substance.
Learn more about bremelanotide.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. Rapid Rx Quiz: Sexual Desire and Performance Medications - Medscape - Apr 11, 2022.
